Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,755
Sort by:
Thromboembolism R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF THROMBOEMBOLISM PIPELINE REPORT INCLUDES Panorama of Thromboembolism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Thrombotic Thrombocytopenic Purpura R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF THROMBOTIC THROMBOCYTOPENIC PURPURA PIPELINE REPORT INCLUDES Panorama of Thrombotic Thrombocytopenic Purpura pipeline markets including statistics on therapeutic drugs and companies involved Thrombotic Thrombocytopenic Purpura Pipeline candidates across various development ...
August 2018
50 pages
Thymic Carcinoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF THYMIC CARCINOMA PIPELINE REPORT INCLUDES Panorama of Thymic Carcinoma pipeline markets including statistics on therapeutic drugs and companies involved Thymic Carcinoma Pipeline candidates across various development ...
August 2018
70 pages
Tinea pedis (Athlete Foot) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF TINEA PEDIS (ATHLETE FOOT) PIPELINE REPORT INCLUDES Panorama of Tinea pedis (Athlete Foot) pipeline markets including statistics on therapeutic drugs and companies involved Tinea pedis (Athlete Foot) Pipeline candidates across ...
August 2018
30 pages
Tinnitus R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF TINNITUS PIPELINE REPORT INCLUDES Panorama of Tinnitus pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Tourette Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TOURETTE SYNDROME PIPELINE REPORT INCLUDES Panorama of Tourette Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Tourette Syndrome Pipeline candidates across various development ...
August 2018
70 pages
Toxoplasmosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF TOXOPLASMOSIS PIPELINE REPORT INCLUDES Panorama of Toxoplasmosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Traveler’s Diarrhea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TRAVELER’S DIARRHEA PIPELINE REPORT INCLUDES Panorama of Traveler’s Diarrhea pipeline markets including statistics on therapeutic drugs and companies involved Traveler’s Diarrhea Pipeline candidates across various development ...
August 2018
40 pages
Trigeminal Neuralgia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TRIGEMINAL NEURALGIA PIPELINE REPORT INCLUDES Panorama of Trigeminal Neuralgia pipeline markets including statistics on therapeutic drugs and companies involved Trigeminal Neuralgia Pipeline candidates across various development ...
August 2018
40 pages
Tularaemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF TULARAEMIA PIPELINE REPORT INCLUDES Panorama of Tularaemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Typhoid Fever R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TYPHOID FEVER PIPELINE REPORT INCLUDES Panorama of Typhoid Fever pipeline markets including statistics on therapeutic drugs and companies involved Typhoid Fever Pipeline candidates across various development ...
August 2018
40 pages
Ureter Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF URETER CANCER PIPELINE REPORT INCLUDES Panorama of Ureter Cancer pipeline markets including statistics on therapeutic drugs and companies involved Ureter Cancer Pipeline candidates across various development ...
August 2018
120 pages
Urinary Incontinence R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF URINARY INCONTINENCE PIPELINE REPORT INCLUDES Panorama of Urinary Incontinence pipeline markets including statistics on therapeutic drugs and companies involved Urinary Incontinence Pipeline candidates across various development ...
August 2018
60 pages
Usher Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF USHER SYNDROME PIPELINE REPORT INCLUDES Panorama of Usher Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Usher Syndrome Pipeline candidates across various development ...
August 2018
30 pages
Uterine Leiomyoma (Uterine Fibroids) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF UTERINE LEIOMYOMA (UTERINE FIBROIDS) PIPELINE REPORT INCLUDES Panorama of Uterine Leiomyoma (Uterine Fibroids) pipeline markets including statistics on therapeutic drugs and companies involved Uterine Leiomyoma (Uterine Fibroids) Pipeline candidates across ...
August 2018
80 pages
Uveal Melanoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF UVEAL MELANOMA PIPELINE REPORT INCLUDES Panorama of Uveal Melanoma pipeline markets including statistics on therapeutic drugs and companies involved Uveal Melanoma Pipeline candidates across various development ...
August 2018
150 pages
Uveitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF UVEITIS PIPELINE REPORT INCLUDES Panorama of Uveitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Vaginal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VAGINAL CANCER PIPELINE REPORT INCLUDES Panorama of Vaginal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Vaginal Cancer Pipeline candidates across various development ...
August 2018
100 pages
Varicella Zoster Infection (HHV-3) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF VARICELLA ZOSTER INFECTION (HHV-3) PIPELINE REPORT INCLUDES Panorama of Varicella Zoster Infection (HHV-3) pipeline markets including statistics on therapeutic drugs and companies involved Varicella Zoster Infection (HHV-3) Pipeline candidates across ...
August 2018
80 pages
Vasculitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF VASCULITIS PIPELINE REPORT INCLUDES Panorama of Vasculitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Venous Leg Ulcers (Crural ulcer) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF VENOUS LEG ULCERS (CRURAL ULCER) PIPELINE REPORT INCLUDES Panorama of Venous Leg Ulcers (Crural ulcer) pipeline markets including statistics on therapeutic drugs and companies involved Venous Leg Ulcers (Crural ulcer) Pipeline candidates across ...
August 2018
50 pages
Ventilator Associated Pneumonia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VENTILATOR ASSOCIATED PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Ventilator Associated Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Ventilator Associated Pneumonia Pipeline candidates across various development ...
August 2018
110 pages
Ventricular Tachycardia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VENTRICULAR TACHYCARDIA PIPELINE REPORT INCLUDES Panorama of Ventricular Tachycardia pipeline markets including statistics on therapeutic drugs and companies involved Ventricular Tachycardia Pipeline candidates across various development ...
August 2018
40 pages
Viral Conjunctivitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VIRAL CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Viral Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Viral Conjunctivitis Pipeline candidates across various development ...
August 2018
30 pages
Visceral Pain R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VISCERAL PAIN PIPELINE REPORT INCLUDES Panorama of Visceral Pain pipeline markets including statistics on therapeutic drugs and companies involved Visceral Pain Pipeline candidates across various development ...
August 2018
40 pages
Vitiligo R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF VITILIGO PIPELINE REPORT INCLUDES Panorama of Vitiligo pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
VRSA Infection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VRSA INFECTION PIPELINE REPORT INCLUDES Panorama of VRSA Infection pipeline markets including statistics on therapeutic drugs and companies involved VRSA Infection Pipeline candidates across various development ...
August 2018
40 pages
Vulvar Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VULVAR CANCER PIPELINE REPORT INCLUDES Panorama of Vulvar Cancer pipeline markets including statistics on therapeutic drugs and companies involved Vulvar Cancer Pipeline candidates across various development ...
August 2018
100 pages
Vulvovaginal Candidiasis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VULVOVAGINAL CANDIDIASIS PIPELINE REPORT INCLUDES Panorama of Vulvovaginal Candidiasis pipeline markets including statistics on therapeutic drugs and companies involved Vulvovaginal Candidiasis Pipeline candidates across various development ...
August 2018
50 pages
Waldenstrom Macroglobulinemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WALDENSTROM MACROGLOBULINEMIA PIPELINE REPORT INCLUDES Panorama of Waldenstrom Macroglobulinemia pipeline markets including statistics on therapeutic drugs and companies involved Waldenstrom Macroglobulinemia Pipeline candidates across various development ...
August 2018
160 pages
Wegener Polyangiitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WEGENER POLYANGIITIS PIPELINE REPORT INCLUDES Panorama of Wegener Polyangiitis pipeline markets including statistics on therapeutic drugs and companies involved Wegener Polyangiitis Pipeline candidates across various development ...
August 2018
50 pages
West Nile Virus Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF WEST NILE VIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of West Nile Virus Infections pipeline markets including statistics on therapeutic drugs and companies involved West Nile Virus Infections Pipeline candidates across ...
August 2018
50 pages
Western Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WESTERN EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Western Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Western Equine Encephalitis Pipeline candidates across various development ...
August 2018
20 pages
Wilson Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WILSON DISEASE PIPELINE REPORT INCLUDES Panorama of Wilson Disease pipeline markets including statistics on therapeutic drugs and companies involved Wilson Disease Pipeline candidates across various development ...
August 2018
40 pages
Women Infertility R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WOMEN INFERTILITY PIPELINE REPORT INCLUDES Panorama of Women Infertility pipeline markets including statistics on therapeutic drugs and companies involved Women Infertility Pipeline candidates across various development ...
August 2018
150 pages
Xerostomia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF XEROSTOMIA PIPELINE REPORT INCLUDES Panorama of Xerostomia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Yellow Fever R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF YELLOW FEVER PIPELINE REPORT INCLUDES Panorama of Yellow Fever pipeline markets including statistics on therapeutic drugs and companies involved Yellow Fever Pipeline candidates across various development ...
August 2018
40 pages
